Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Importin-4 is a member of the karyopherin/importin-β family of nuclear transport receptors, encoded by the *IPO4* gene. It recognizes nuclear localization signals (NLS) on cargo proteins, binds them in the cytoplasm, and assists their transport through the nuclear pore complex by interacting with nucleoporins. The translocation process is energy-dependent and regulated by the Ran GTPase system, which specifies the directionality of import. Importin-4 plays key roles in protein import into the nucleus, chromatin assembly, and intracellular transport, and is implicated in disease contexts such as certain cancers and congenital anemias.
No FDA-approved drugs with defined mechanisms of action against Importin-4; theoretically, inhibitors would block nuclear import of cargo proteins by disrupting NLS recognition, substrate binding, or import complex translocation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Importin-4 (IPO4).